Goldman Sachs’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.03M | Buy |
1,561,585
+214,370
| +16% | +$857K | ﹤0.01% | 3365 |
|
|
2025
Q4 | $5.13M | Sell |
1,347,215
-227,786
| -14% | -$886K | ﹤0.01% | 3720 |
|
|
2025
Q3 | $5.09M | Buy |
1,575,001
+1,443,379
| +1,097% | +$5.41M | ﹤0.01% | 3636 |
|
|
2025
Q2 | $380K | Sell |
131,622
-2,539,649
| -95% | -$5.88M | ﹤0.01% | 5319 |
|
|
2025
Q1 | $5.74M | Sell |
2,671,271
-1,480,957
| -36% | -$4.68M | ﹤0.01% | 3217 |
|
|
2024
Q4 | $16.1M | Sell |
4,152,228
-97,263
| -2% | -$642K | ﹤0.01% | 2345 |
|
|
2024
Q3 | $27.8M | Sell |
4,249,491
-83,302
| -2% | -$669K | ﹤0.01% | 1762 |
|
|
2024
Q2 | $31.4M | Buy |
4,332,793
+915,195
| +27% | +$7.01M | 0.01% | 1504 |
|
|
2024
Q1 | $25.9M | Buy |
3,417,598
+3,283,731
| +2,453% | +$25.6M | ﹤0.01% | 1624 |
|
|
2023
Q4 | $609K | Sell |
133,867
-1,734
| -1% | -$5.85K | ﹤0.01% | 4648 |
|
|
2023
Q3 | $536K | Buy |
135,601
+504
| +0.4% | +$1.91K | ﹤0.01% | 4626 |
|
|
2023
Q2 | $423K | Sell |
135,097
-41,784
| -24% | -$170K | ﹤0.01% | 4826 |
|
|
2023
Q1 | $801K | Buy |
176,881
+64,195
| +57% | +$335K | ﹤0.01% | 4540 |
|
|
2022
Q4 | $465K | Buy |
112,686
+51,756
| +85% | +$177K | ﹤0.01% | 4905 |
|
|
2022
Q3 | $195K | Buy |
+60,930
| New | +$153K | ﹤0.01% | 5496 |
|
|
2021
Q4 | – | Sell |
-13,053
| Closed | -$151K | – | 6593 |
|
|
2021
Q3 | $151K | Sell |
13,053
-1,261
| -9% | -$15.1K | ﹤0.01% | 5818 |
|
|
2021
Q2 | $141K | Buy |
+14,314
| New | +$162K | ﹤0.01% | 5862 |
|
|
2020
Q2 | – | Sell |
-3,118
| Closed | -$29K | – | 5365 |
|
|
2020
Q1 | $29K | Sell |
3,118
-832
| -21% | -$10.9K | ﹤0.01% | 5099 |
|
|
2019
Q4 | $53K | Sell |
3,950
-21,455
| -84% | -$205K | ﹤0.01% | 5112 |
|
|
2019
Q3 | $225K | Sell |
25,405
-31,792
| -56% | -$349K | ﹤0.01% | 4785 |
|
|
2019
Q2 | $817K | Buy |
57,197
+40,280
| +238% | +$1.07M | ﹤0.01% | 4117 |
|
|
2019
Q1 | $556K | Sell |
16,917
-789
| -4% | -$40.4K | ﹤0.01% | 4373 |
|
|
2018
Q4 | $1.05M | Buy |
17,706
+4,244
| +32% | +$419K | ﹤0.01% | 3941 |
|
|
2018
Q3 | $1.89M | Buy |
13,462
+8,335
| +163% | +$1.01M | ﹤0.01% | 3649 |
|
|
2018
Q2 | $629K | Sell |
5,127
-8,538
| -62% | -$725K | ﹤0.01% | 4378 |
|
|
2018
Q1 | $1.22M | Buy |
+13,665
| New | +$1.16M | ﹤0.01% | 3921 |
|
|
2017
Q4 | – | Sell |
-999
| Closed | -$42K | – | 6525 |
|
|
2017
Q3 | $42K | Sell |
999
-15,442
| -94% | -$642K | ﹤0.01% | 6291 |
|
|
2017
Q2 | $692K | Buy |
16,441
+15,528
| +1,701% | +$794K | ﹤0.01% | 4795 |
|
|
2017
Q1 | $51K | Sell |
913
-1,677
| -65% | -$83.3K | ﹤0.01% | 6280 |
|
|
2016
Q4 | $99K | Buy |
2,590
+20
| +0.8% | +$811 | ﹤0.01% | 6147 |
|
|
2016
Q3 | $102K | Buy |
2,570
+1,222
| +91% | +$55.5K | ﹤0.01% | 6216 |
|
|
2016
Q2 | $97K | Buy |
+1,348
| New | +$107K | ﹤0.01% | 6143 |
|
|
2016
Q1 | – | Sell |
-4,495
| Closed | -$339K | – | 7214 |
|
|
2015
Q4 | $339K | Buy |
+4,495
| New | +$722K | ﹤0.01% | 5251 |
|
|
2015
Q3 | – | Sell |
-11,716
| Closed | -$4.87M | – | 7407 |
|
|
2015
Q2 | $4.87M | Buy |
11,716
+9,847
| +527% | +$4.12M | ﹤0.01% | 2991 |
|
|
2015
Q1 | $888K | Sell |
1,869
-3,146
| -63% | -$1.49M | ﹤0.01% | 4588 |
|
|
2014
Q4 | $1.86M | Sell |
5,015
-438
| -8% | -$113K | ﹤0.01% | 3916 |
|
|
2014
Q3 | $1.29M | Buy |
+5,453
| New | +$1.24M | ﹤0.01% | 4353 |
|
Other funds holding LRMR
DM
BOCH
ACM
DCM
VCM
DCM
DTC
RI